PES and aGVHD in the Toci and No Toci patient groups. (A) The cumulative incidence of PES was of 38% (95% CI, 24-52) in the Toci group vs 72% (95% CI, 54-84) in the No Toci group (P < .001). (B) The cumulative incidence of grade 2 to 4 aGVHD was 71% (95% CI, 55-82) in the Toci group vs 82% (95% CI, 65-91) in the No Toci group (P = .11). (C) The cumulative incidence of grade 3 to 4 aGVHD was 11% (95% CI, 4-22) in the Toci group vs 23% (95% CI, 11-37) in the No Toci group (P = .13). (D) The cumulative incidence of stage 1 to 4 lower GI GVHD by day 100 was 16% (95% CI, 7-28) in the Toci group vs 33% (95% CI, 19-48) in the No Toci group (P = .059).